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Genetics disorders a key role in predisposition to 
colorectal cancer (CRC) in its initiation and progres-
sion. CRC provides a useful model for understanding 
cancer genetics because CRC development is a multi-
step process in the majority of cases [1], based on the 
mutations in several genes. The discovery of genes, 
involved in carcinogenesis and associated with CRC, 
including hereditary cancer (p53, К-ras, MLH1, MSH2, 
etc.), play an important role in the creation of the spe-
cific highly sensitive tests [2, 3]. Another genetic test 
is based on determination of DNA quantity in tumor 
cells using cytospectrophotometric analysis, due to 
significant role of the changes in DNA content (ploidy 
level) during the clinical course of CRC adenocarcino-
mas. This method allows to reveal domination of the 
polyploid cells in colorectal tumors and correlation of 
polyploidy with histologically confirmed carcinomas 
[4]. However, it is not suitable for the evaluation of the 
spectrum of cytogenetic changes and their prognostic 
significance.
There is an evident linkage between the appearance 
of structural and functional alterations in the chromo-
somes of tumor cells and the origin of CRC. The results 
of cytogenetic and molecular genetic methods confirm 
the consequent development of impairments in large 
bowel (perhaps, except hereditary non-polyposis 
CRC — Lynch syndrome) [3, 5, 6]. It means that each 
step of malignancy may accompany chromosomal 
changes. It is considered that in the majority CRC ade-
nocarcinomas originate on the basis of polyps. Unlike 
single adenomatous polyps (as a rule histologically 
benign), multiple polyps (such as familial adenomatous 
polyps — FAP), possess extremely high malignancy in-
dex. Therefore, the morphological structure is the same 
in adenomas, both single (non-hereditary form of the 
disease) and multiply (hereditary form). Nevertheless, 
the frequency of malignancy in both cases is different. 
Literature data are rather controversial regarding the 
spectrum and the prognostic value of the chromosome 
rearrangements during development of CRC [7–12], 
and the search for informative genetic criteria for early 
diagnosis of CRC is required.
The aim of this work is to compare the spectrum 
of chromosome changes in colorectal adenomas and 
adenocarcinomas, and to evaluate the prognostic sig-
nificance of chromosome rearrangements in CRC.
MATERIALS AND METHODS
Patients (n = 56) with clinically, endoscopically 
and histologically confirmed diagnosis of colorectal 
adenomas and adenocarcinomas were cured in the 
Department of Surgical Diseases of Danylo Halytsky 
Lviv National Medical Universiti, Lviv, Ukraine in 
1998–2008. All studies were performed according to 
the Institution’s Ethical Committee regulations, and 
written consents from patients were obtained.
The hereditary nature of the diseases was confirmed 
using genealogical analysis. Colorectal adenomas 
(n = 38) were classified as tubular adenomas of single 
polyps (n = 9), tubulovillous adenomas (n = 10), villous 
adenomas (n = 10), and tubular adenomas (FAP) (n = 9). 
All patients with sporadic adenomas were 33 to 86 years 
old (median age = 64.2 years), and patients with FAP 
were 22 to 56 years old (median age = 40.8 years).
Patients with adenocarcinoma of large bowel 
(n = 18) were from 45 to 76 years old (median 
age = 61.7 years). CRC tumor progression was es-
timated using the TNM classification. Chromosome 
abnormalities were described according to the stan-
dard International System for Human Cytogenetic 
Nomenclature [13].
Preparation of the biopsy material of adenomas 
specimens for cytogenetic analysis was performed 
according to a standard technique [8] with own 
modification of cell fixation technique. The metaphase 
chromosomes of adenocarcinomas specimens were 
obtained by our own method [14].
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The specimens of tumors were mechanically dis-
rupted, washed in a Hanks solution. Then the mate-
rial was placed in flask with Igle medium with double 
set of aminoacids, 0.5 μg/ml colchicine solution and 
ethidium bromide. Then the cells were placed in a 
mixture of 0.075 M KCl and 1% sodium citrate, fixed in 
ethanol and acetic acid, and macerated or dropped. 
The specimens were differentially stained with the 
Romanovskyy — Gimsa stain dissolved in the phos-
phate buffer (рН 6.8) supplemented with 0.25% tripsin 
solution. 5–23 metaphase plates per specimen were 
analyzed.
RESULTS AND DISCUSSION
The karyotype peculiarities (the spectrum of 
chromosome anomalies and the sets with alterated 
ploidy) were studied in morphologically different be-
nign tumors of large bowel. Aneuploidy prevailed in 
the spectrum of chromosome anomalies in single 
adenomas. The additional copies of chromosomes 
7, 13, 18, 20 and their combinations (7 and 13; 7 and 
20, 13 and 20 and al.) were the most frequent abnor-
malities. Eleven (37.9%) sporadic adenomas and two 
adenomas with infiltrating carcinoma had abnormal 
karyotypes. The karyotype was normal in remaining 
cases. The abnormal karyotype in tubular adenomas 
was found in 3 from 9 (33.3%) cases. Chromosome 
abnormalities appeared more frequently in tubulovil-
lous and in villous adenomas: 4 from 10 (40%) and 
6 out of (60.0%) cases, respectively. The spectrum of 
chromosome abnormalities and the degree of epithe-
lial dysplasia in the adenomas are shown in Table 1.
The adenoma in sigmoid colon was observed in one 
case on the height of 35 cm from the anus, located on 
the distance of 25 cm lower than high differentiated 
adenocarcinoma in 57-years old patient (case 13, 
Table 1). This adenoma with severe dysplasia had 
0.7 x 0.5 cm dimensions. The combination of addi-
tional copies of chromosomes 13, 18 and 20 was found 
in the karyotype of this adenoma (Fig. 1).
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Fig. 1. Karyotype: 48,XY,+13,+18,+20. Villous adenomas of 
sigmoid colon: a, metaphase plate; b, ideogram
In the cases of in situ adenocarcinoma the meta-
phase plates contained chromosomal sets with alter-
ated ploidy with modal quantity from 78 to 130 chromo-
somes (case 7, Table 1), fragment of chromosome that 
developed as a result of chromosome deletion, and 
additional copies of chromosomes 7 and 20 (case 8, 
Table 1). Some authors report quantitative changes 
of several chromosomes (2, 7, 14) in cases of these 
intermediate conditions (Table 2) [8, 9].
Table 1. The karyotypes of sporadic and familial adenomas with different degree of epithelial dysplasia
Types of ade-
nomas
Adenomas loca-
lization
N of 
case Karyotype The degree of epithelial dysplasia
Sporadic form
Tubular ade-
nomas
Sigmoid colon 1 47,XX,+7[8]*; Severe
Sigmoid colon 2 47,XY,+7[2]*/48,XY,+7,+13[6]*; Severe
Sigmoid colon 3 47,XX,+7[3]*/48,XX,+7,+13[3]* Severe
Tubular-vil-
lous ade-
nomas
Descending colon 4 49,XY,+13,+20,+20[2]*/48,XY,+13,+20[7]*; Severe
Sigmoid colon 5 48,XY,+13,+20[3]*/49,XY,+13,+18,+20[6]*; Severe
Sigmoid colon 6 52,XY,+7,+del(8q),+13,+14,+15,+20[3]*/50,XY,+7,+13,+15,+20[8]*; Severe
Sigmoid colon 7 78,XXX[4]*/82,XXXX[1]/130,XXXXX[1]* Severe with areas of carcinoma in situ
Villous ade-
nomas
Rectum 8 48,XY,+7,+20[3]*/49,XY,+7,+20,+mar[5]*; Severe with areas of carcinoma in situ
Rectum 9 49,XY,+7,+13,+16[2]*/48,XY,+7,+13[7]*; Severe
Sigmoid colon 10 72,XXX[4]*/76,XXX[2]*/130,XXXXX[1]*; Severe
Rectum 11 84,XXXYYY[4]*/89,XXXXYYYY[1]*/95,XXXXYYYY[2]*; Severe
Rectum 12 47,XY,del (3p),+13[5]*; Severe
Sigmoid colon 13 47,XY,+13[3]*/48,+13,+18[2]*/49,XY,+13,+18,+20[2]*; Severe
FAP
Tubular ade-
nomas
Rectum 14 48,XX,+7,+13[7]*; Severe
Sigmoid colon 15 48,XX,+12,+16[2]*/52,XX,+3,+12,+16,+18,+19,+20[4]*/64,XXX[1]*/67,XXX[1]*; Severe
Rectum 16 47,XY,1p-,+7,+mar,-17/[3]*/65,XXXY,1p-,+7,+mar,-17/[9]* Severe with areas of carcinoma in situ
Rectum 17 47,XX,+7[5]* Severe
Notes: 5–12 metaphase plates per specimen were analyzed. *Number of metaphase plates analyzed for each sample.
Таble 2. Spectrum of chromosome abnormalities in single adenomas, in adenomas from patients with hereditary polyposis and in in situ adenocarcino-
mas according to own results and the literature data
Type of tumor
Aneuploidy Structural chromosome rearrangements
Additional copies of 
chromosomesІ
Additional copies of chro-
mosomes
ІІ
Deletions
І
Deletions
ІІ
Translo cations
І
Translo cations
ІІ
Аdenomas (sporadic form of polyps) 7, 8, 13, 14, 15, 16, 18, 20 1, 2, 5, 6, 7, 8, 9, 10, 13, 
14, 15, 16, 19, 20, 22
3p, 8q 3p, 10q, – (3; 14);
(10; 15).
Аdenomas (hereditary form of polyps) 7, 12, 13, 16, 18, 19, 20 7, 8, 13 – – – –
Аdenomas with with areas of carcino-
ma in situ (sporadic form of polyps)
Modal quantity (78–130) 2, 7, 14 – 5р – –
Аdenomas with infiltrating adenocarci-
nomas (hereditary form of polyps)
Modal quantity (47–65) 2, 3, 8, 9, 12, 13, 14, 19, 20 1p – – –
Notes: I — own results; II — literature data [7–9].
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We have observed different spectrum of chromo-
some abnormalities in the adenomas from patients 
with FAP. The chromosome abnormalities were found 
in 4 out of 9 (44.4%) patients with FAP. Three cases 
(from these 4) were represented by aneuploid sets 
with additional copies of the chromosomes 7, 12, 13, 
16, 18, 19, 20 with different combinations. The aneu-
ploid changes detected at early stages may underlie 
accelerated tumor progression, increased cancer 
risk and poor prognosis. FAP adenomas were char-
acterized by gains affecting chromosomes 7 and 13 
[12]. One patient with Gardner syndrome (the variant 
of FAP) had CRC complicated with hepatoblastoma; 
the karyotype of adenomas was mosaic with combi-
nation of different cell clones containing from 47 tо 
66 chromosomes, when the prevailing cell clone was 
near-triploid with modal chromosome quantity from 
60 to 66 with fragments of deleted chromosomes of 
unknown origin and losses chromosome 1p, 17 (16, 
Table 1). The pedigree of family with FAP of patient 
with polyposis is shown on Fig. 2. The proband and 
his affected relatives carried the mutation c.3343delA 
in the APC gene. The diagnosis was confirmed using 
molecular genetic analysis in the Institute of Human 
Genetics of Polish Academy of Sciences.
FAP
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Fig. 2. The pedigree of family with FAP and colorectal cancer. 
The proband and his affected relatives (brother and 2 neph-
ews) carried the mutation c.3343delA in the APC gene. The 
karyotype of the FAP adenoma (N16, Table 1) as follows: 
47,XY,1p-,+7,+mar,-17/[3]/66,XXXY,1p-,+7,+mar,-17/[9]*
Comparison of the spectrum of chromosome 
abnormalities in single adenomas, adenomas from 
patients with hereditary polyposis and in adenocar-
cinomas in situ (according to our own results and the 
literature data) is shown in Table 2.
The chromosome abnormalities were found in 
100% cases of adenocarcinoma bioptates. The local-
ization of tumors in large bowel was as follows: rectal 
in 15 patients (83.3%); sigmoid, transversal and left 
colon localization had single patients (5.5% for each 
localization) (Table 3).
The quantity of the cell clones of tumors with 
alterated ploidy (near-diploid, near-triploid and 
near-tetraploid) were observed. The karyotype of 
adenocarcinomas had wide intratumoral chromosomal 
variations. During tumor progression many clones 
were generated. Anatomy and clinical data, and modal 
number of chromosomes in cell clones for each case 
are shown in Table 3.
Тable 3. Clinical and chromosomal data from colorectal adenocarcinomas
Sex/Age Localization of neoplasm
TNM classifica-
tion of tumors
Modal number of chromo-
somes in cell clones
1.F/58 Rectum pT1N0MoG1 51[2]/72[11]
2.M/59 Rectum pT3N1M0G1 51-54[9]/96-104[2]
3. F/54 Rectum pT3N1M0G1 43- 48[6]
4.M/76 Rectum pT3N1M0G1 47[2]/58-64[21]
5.F/62 Transversum colon pT2NoM0G1 67-78[13]/82-86[4]
6.M/72 Rectum pT1N0M0G1 76-80[5]
7.F/54 Sigmoid colon pT1N0M0G1 63-74[6]
8.M/54 Rectum pT3N1M0G2 58-71[7]
9.F/51 Rectum pT3N0M0G2 39-50[12]
10.M/69 Rectum pT3N1M0G2 40-44[9]
11.M/58 Rectum pT3N1M0G2 48-52[3]/65-72[5]
12.F/61 Rectum pT3N1M0G2 40-42[2]/68-75[6]
13.F/61 Rectum pT2N0M0G2 62-70[5]
14.M/75 Rectum pT4N1M1G2 48-51[6]/68-72[4]/86-
109[4]
15. F/45 Rectum pT4N1M1G2 43-54[3]/62-70[3]
16.F/58 Rectum pT4N1M1G2 50-57[6]/60-69[6]/96-112[3]
17.F/74 Left pT3N1M1G3 41-43[10]
18.F/71 Rectum pT3N1M1G3 41-45[16]
The analysis of metaphasal plates had shown that 
there were more near-triploid cell clones (< 3n, > 3n 
chromosomes, 92 clones), less near-diploid cell 
clones (< 2n, > 2n chromosomes, 83 clones), and the 
least were near-tetraploid cell clones and clones with 
higher ploidy (< 4n, > 4n chromosomes, 13 clones). 
Thus, we determined 5 polysomal, 5 monosomal and 
8 mixed-type tumors. The types of ploidies in adeno-
carcinomas of large bowel are shown on Fig. 3.
Fig. 3. The types of ploidy in adenocarcinomas of large bowel
Aneuploid chromosome sets were present in the 
karyotype of adenocarcinomas with additional copies 
of chromosomes 3, 16, 17, 18, 19, 20, 21, 22 in different 
combinations. Genomic instability is a crucial step in CRC 
progression and occurs in two ways. DNA mismatch re-
pair deficiency leading to microsatelite instability (15% of 
cases). Genomic instability may occur at the chromosomal 
level and give rise to aneuploidy (85% of cases) [16].
Numerous chromosome rearrangements with high 
intratumoral heterogeneity of the karyotype, with three 
types of ploidy and numerous deleted chromosomes 
in the group of patients with poor prognosis have been 
determined. For example, patient 14 (see Table 3) had 
moderately-differentiated adenocarcinomas with low-
differentiated areas and with disintegration set. We 
revealed a very heterogenous karyotype with 6 diffe-
rent cell clones in the specimens of adenocarcinoma, 
4 of these are the following:
a) 48,XY,+16,+19,+20,-18[4]*/
b) 51,XY,+3,+13,+14,+16,+19,+mar1,+mar2,-17,-18[2]*/
c) 72,XXXYYY,+1(3),+2(6),+3(4),+5(6),+7(5),+
10(4),+11(5),+12(3),+13(3),+14(3),+15(4),+16 
(3),+19(3),+20(4),+mar,-17,-18[2]*/
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d) 109,XXXYYYY,+1(4),+2(8),+3(4),+5(6),+6(3),del 6(?)q-, 
+7(7),+9(3),+10(4),+11(5),+12(4),+13(5),+14(5),+15(5),
+16(4),+19(5),+20(10), +mar1(5),+mar2,-18,-8[2]*,
where are numbers of analyzed clones.
There are many copies of some chromosomes (from 
4 copies of chromosomes 1, 3, 6, 12, 16, Y to 5-7 co-
pies of chromosomes 4, 5, 7, 11, 13, 14, 15, 19, to 8 — 
10 copies of chromosomes 2, 20) with simultaneously 
numerous copies of pointed deleted chromosomes and 
with monosomy of chromosomes 8, 17, 18. According 
to the literature data, gain of 20q is observed in more 
than 65% of CRC. Gains of 20q are also common in 
other tumor types and have been associated with poor 
outcome in gastric cancer and CRC [15–18].
The microphoto of one clone with near-pentaploid 
karyotype is shown in Fig. 4.
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Fig. 4. Karyotype: 109, XXXYYYY (cell clone N1). Moderately dif-
ferentiated adenocarcinomas with low-differentiated areas and 
with seat of disintegration: a, metaphase plate; b, ideogram
The analogous heterogeneous karyotype with three 
types of ploidy and numerous deleted chromosomes were 
observed in another adenocarcinoma sample (case 16). 
Patient also had rectal polyp and adenocarcinoma of 
uterus and right ovary. The near-diploid cell clone with 
56 chromosomes included trisomy of 12 chromosomes 
and other rearrangements: 56,XX, 1p-,+3,+16,+17,+18, 
+19,+19,+20,+20,+21,+21,+22,+mar,-12,-14.
The poor prognostic cytogenetic feature was an 
appearance of monosomal type of tumor with allelic 
losses of 18, 6, 11, 14 and X chromosomes (cases 17, 
18) and the presence of numerous deleted chromo-
somes (case 15). Deletions of some chromosomes were 
found in 12 (66.7%) tumor samples. The size of deleted 
chromosomes was variable and fluctuated from small 
metacentric to acrocentric chromosomes, and some-
times their origin can’t be established using G-method. 
The most frequently deleted chromosome of A-group 
was chromosome 1 (del 1p) (cases 16, 17).
Thus, the origin of tumors of large bowel is frequently 
characterized by alterations on the chromosomal level. 
The majority of the karyotypes of adenomas are normal, 
but in some tumors with severe dysplasia of epithelium 
the quantitative chromosome abnormalities and structural 
rearrangements were determined. The most typical chro-
mosome abnormalities were numerical, such as trisomies 
of chromosomes 7, 13, 14, 16, 18, 20. Molecular genetic 
studies confirmed the arising of the genetic abnormalities 
during the progression from polyp to carcinoma. The gene 
involved in FAP was localized to 5q21 and was identified 
as APC. Molecular studies of adenomas have described 
allelic loss involving 5q, 18q, 17p. At the cytogenetic level 
chromosome losses in adenoma also occurs, but loss of 
5q was detected only in few samples [12].
The combination of different malignant tumors (ade-
nocarcinomas with adenomas) leads to the appearance 
of abnormal cell clones with additional copies of chro-
mosomes 13, 18 and 20. The transition from tubular to 
tubular-villous and villous adenomas was accompanied 
by the increase of chromosome abnormalities quantity 
from 33.3% to 60,0% and widening of the spectrum of 
abnormalities (deletions, translocations). The quantity 
of the chromosome anomalies doesn’t reach more 
than 40% cases for the hereditary form of polyposis, 
despite of domination of tubular adenoma with different 
degree of dysplasia. The features of malignant growth of 
adenomas are manifested by aneuploidy and chromo-
some deletions. The alteration of ploidy may also oc-
cur, although this phenomenon is comparatively rare in 
adenomas (polyploidy was present in 10% of cases).
Numerous adenocarcinomas possess polysomic 
karyotype with near-triploid or near-tetraploid or more 
chromosomal sets. Elevation of clonal variety, selective 
accumulation of the copies of some chromosomes with 
simultaneously monosomy of another and deletions are 
typical for adenocarcinomas. Allelic losses of chromo-
somes 18, 17, 6, 8, 11, 14 and X, appearance of additional 
copies of chromosomes 2, 3, 20, 16 and structural rear-
rangements (deletions) are of significant value in tumor 
progression. Monosomy and partial monosomy of 
chromosome 1, 3, 17, 18 led to tumor progression, due 
to the existence of recessive tumor suppressor genes, 
located on the 18q and 17p chromosomes. According to 
the literature data, the expression of oncogenes (N-ras, 
ski), located on the chromosome 1, also lead to cell ma-
lignization and CRC progression. The high probability of 
alterations in 27 genes on chromosome 3 confirmed to 
play the role in colorectal cancerogenesis [19].
In conclusion, the majority of chromosome abnor-
malities in colorectal adenomas were numerical, such 
as trisomies of chromosomes 7, 13, 14, 16, 18, 20. 
The adenomas with a high-grade epithelial dysplasia 
possess abnormal karyotype in all cases. The aneuploid 
changes, such as gains of chromosome 7, monosomy 
of 17 and 1p-, in FAP adenomas may lead to accelera-
ted tumor progression, increased cancer risk and poor 
prognosis. The chromosome abnormalities were found 
in 100% of cases in adenocarcinoma bioptates. We de-
termined 5 polysomal, 5 monosomal type and 8 mixed-
type tumors. Numerous chromosome rearrangements 
with high intratumoral heterogeneity of the karyotype 
with three types of ploidy and numerous deleted chro-
mosomes were determined in the group of patients 
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with poor prognosis. Appearance of monosomal type 
adenocarcinomas with allelic losses of chromosomes 
18, 6, 11, 14 and X, and the presence of numerous de-
leted chromosomes were cytogenetic features of CRC 
with poor prognostic value.
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